The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
R. K. Shenoy(T. D. Medical College), Kesara Na‐Bangchang(Thammasat University), Anil John(University of Benin), S Arun(T. D. Medical College), V. Kumaraswami(National Institute of Research in Tuberculosis), Lawrence Fleckenstein(University of Iowa), Takeshi Suma(T. D. Medical College)
Cited by 40
Related Papers
Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
|Annals of Tropical Medicine and Parasitology|2000|39